Description
Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.
- PrevisEA Commitments: 2 hospitals systems (63 hospitals) $21M revenue oppy
- In review: 7 systems (74 hospitals) - $41M opportunity. Commitment due
- Engaged: 5 systems (66 hospitals) - $46M opportunity - Expected in 2025.
Location
-
209 East Washington Street suite 200a, Iowa City, IA 52240, USA
Region
- North America
Business Details
-
Funding StageGrowth / Expansion
-
Business ModelB2B2C
-
Team SizeLarge (16- 50)
Is this Business for Sale?
- No

Add a review